<DOC>
	<DOCNO>NCT02581553</DOCNO>
	<brief_summary>This study assess relative bioavailability lesinurad/allopurinol fix dose combination ( FDC ) , individual component effect food .</brief_summary>
	<brief_title>Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability</brief_title>
	<detailed_description>The study comprise 2 part . Part 1 ass relative BA lesinurad/allopurinol FDC monocomponents fast subject . Part 2 assess effect food PK FDC tablet .</detailed_description>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Lesinurad</mesh_term>
	<criteria>Body mass index range 18 kg/m2 40 kg/m2 . Screening serum urate level â‰¤ 7.0 mg/dL . Asian subject positive test HLAB*5801 allele . History suspicion kidney stone . Estimated creatinine clearance , determine Screening , &lt; 90 mL/min calculate CockcroftGault formula use ideal body weight . Undergone major surgery within 3 month prior Screening . Donated blood experience significant blood loss ( &gt; 450 mL ) within 12 week prior Day 1or give plasma donation within 4 week prior Day 1 . Inadequate venous access unsuitable vein repeat venipuncture . Received strong moderate enzymeinducing drug product within 2 month prior Screening .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>